Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Semiconductors

>>

Transmucosal Drug Delivery Devices Market


Transmucosal Drug Delivery Devices Market By Type (Buccal Route, Rectal Route, Nasal Route), By Application (Hospital, Residential), Regional Outlook, Competitive Landscape, Market Share Analysis and Forecast, 2018-2024

Report code: SDMRSE607703 | Industry: Semiconductors  | Published On: 8/15/2019


Industry Insights
The global Transmucosal Drug Delivery Devices market is expected to grow at an anticipated CAGR of 5.3% over the forecast period. Growing usage of transmucosal drug delivery devices both in hospital and residential applications, government efforts to boost medical infrastructure and rising standard of living prompting to increased medical spending are expected to benefit the overall market growth.

The global Transmucosal Drug Delivery Devices market is segmented on the basis of Type and Application. The global Transmucosal Drug Delivery Devices market is segmented based on Type as Buccal Route, Rectal Route, and Nasal Route. Based on Application the global Transmucosal Drug Delivery Devices market is segregated as Hospital and Residential.
The regional outlook on the global Transmucosal Drug Delivery Devices market covers regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Transmucosal Drug Delivery Devices market for each region is further bifurcated for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Landscape
Companies are trying to develop products in line with the current trends and developments. For example, companies have introduced products which can be used in residential applications as well. The global Transmucosal Drug Delivery Devices market is highly competitive in nature with major players including Allergan, Amphastar Pharmaceuticals Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aquestive Therapeutics Inc, Callitas Therapeutics Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, and others. The report covers competitive analysis on the key market share holders. The companies are focused on several expansion and growth strategies to enhance their footprint in the Transmucosal Drug Delivery Devices market. Market players are also involved in value chain integration gain competitive advantage.
Report Scope:
The Transmucosal Drug Delivery Devices market report scope covers the in-depth business analysis considering major market dynamics, forecast parameters, and price trends for the industry growth. The report forecasts market sizing at global, regional and country levels, providing comprehensive outlook of industry trends in each market segments and sub-segments from 2017 to 2024. The market segmentations include,
Transmucosal Drug Delivery Devices Market, By Type
• Buccal Route
• Rectal Route
• Nasal Route
Transmucosal Drug Delivery Devices Market, By Application
• Hospital
• Residential
Transmucosal Drug Delivery Devices Market, By Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
The report scope also includes competitive landscape covering the competitive analysis, strategy analysis and company profiles of the major market players. The companies profiled in the report include Allergan, Amphastar Pharmaceuticals Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aquestive Therapeutics Inc, Callitas Therapeutics Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, and others. Company profiles cover company overview, product landscape, financial overview, and strategy analysis.
Report Highlights
• Global Transmucosal Drug Delivery Devices market sizes from 2017 to 2024
• Market growth projections through 2024 and the resultant market forecast for 2024
• Impact of the market dynamics including market drivers, restraints and opportunities in the market size
• Key industry trends, product trends, and application trends
• Major driving/ leading segmentations, regions and countries in the global Transmucosal Drug Delivery Devices market
• Competitive analysis with comprehensive company profiles of the leading industry players
• In-depth analysis on growth and expansion strategies adopted by market players and their resulting effect on market growth and competition
Report Customizations
The customization research services cover the additional custom report features such as additional regional and country level analysis as per the client requirements.

Table  of  Contents

1.  Introduction
1.1  Key  Insights
1.2  Report  Overview
1.3  Markets  Covered
1.4  Stakeholders
2.  Research  Methodology
2.1  Research  Scope
2.2  Market  Research  Process
2.3  Research  Data  Analysis
2.4.1  Secondary  Research
2.4.2  Primary  Research
2.4.3  Models  for  Estimation
2.5  Market  Size  Estimation
2.5.1  Bottom-Up  Approach  -  Segmental  Market  Analysis
2.5.2  Top-Down  Approach  -  Parent  Market  Analysis
3.  Executive  Summary
4.  Market  Overview
4.1  Introduction
4.2.1  Drivers
4.2.2  Restraints
4.2.3  Opportunities
4.2.4  Challenges
4.2  Porter's  Five  Force  Analysis
5.  Transmucosal  Drug  Delivery  Devices  Market,  By  Type
5.1  Introduction
5.2  Buccal  Route
5.2.1  Market  Overview
5.2.2  Market  Size  and  Forecast
5.3  Rectal  Route
5.3.1  Market  Overview
5.3.2  Market  Size  and  Forecast
5.4  Nasal  Route
5.4.1  Market  Overview
5.4.2  Market  Size  and  Forecast
6.  Transmucosal  Drug  Delivery  Devices  Market,  By  Application
6.1  Introduction
6.2  Hospital
6.2.1  Market  Overview
6.2.2  Market  Size  and  Forecast
6.3  Residential
6.3.1  Market  Overview
6.3.2  Market  Size  and  Forecast
7.  Transmucosal  Drug  Delivery  Devices  Market,  By  Geography
7.1  Introduction
7.2  North  America
7.2.1  North  America  Transmucosal  Drug  Delivery  Devices,  By  Type
7.2.2  North  America  Transmucosal  Drug  Delivery  Devices,  By  Application
7.3  Europe
7.3.1  Europe  Transmucosal  Drug  Delivery  Devices,  By  Type
7.3.2  Europe  Transmucosal  Drug  Delivery  Devices,  By  Application
7.4  Asia-Pacific
7.4.1  Asia-Pacific  Transmucosal  Drug  Delivery  Devices,  By  Type
7.4.2  Asia-Pacific  Transmucosal  Drug  Delivery  Devices,  By  Application
7.5  Rest  of  the  World
7.5.1  Rest  of  the  World  Transmucosal  Drug  Delivery  Devices,  By  Type
7.5.2  Rest  of  the  World  Transmucosal  Drug  Delivery  Devices,  By  Application
8.  Competitive  Insights
8.1  Key  Insights
8.2  Company  Market  Share  Analysis
8.3  Strategic  Outlook
8.3.1  Mergers  &  Acquisitions
8.3.2  New  Product  Development
8.3.3  Portfolio/Production  Capacity  Expansions
8.3.4  Joint  Ventures,  Collaborations,  Partnerships  &  Agreements  
8.3.5  Others
9.  Company  Profiles
9.1  Allergan
9.1.1  Company  Overview
9.1.2  Product/Service  Landscape
9.1.3  Financial  Overview
9.1.4  Recent  Developments
9.2  Amphastar  Pharmaceuticals  Inc
9.2.1  Company  Overview
9.2.2  Product/Service  Landscape
9.2.3  Financial  Overview
9.2.4  Recent  Developments
9.3  ARS  Pharmaceuticals
9.3.1  Company  Overview
9.3.2  Product/Service  Landscape
9.3.3  Financial  Overview
9.3.4  Recent  Developments
9.4  Combinent  BioMedical  Systems  Inc
9.4.1  Company  Overview
9.4.2  Product/Service  Landscape
9.4.3  Financial  Overview
9.4.4  Recent  Developments
9.5  Aquestive  Therapeutics  Inc
9.5.1  Company  Overview
9.5.2  Product/Service  Landscape
9.5.3  Financial  Overview
9.5.4  Recent  Developments
9.6  Callitas  Therapeutics  Inc
9.6.1  Company  Overview
9.6.2  Product/Service  Landscape
9.6.3  Financial  Overview
9.6.4  Recent  Developments
9.7  Aegis  Therapeutics  LLC
9.7.1  Company  Overview
9.7.2  Product/Service  Landscape
9.7.3  Financial  Overview
9.7.4  Recent  Developments
9.8  Bespak  Europe  Ltd
9.8.1  Company  Overview
9.8.2  Product/Service  Landscape
9.8.3  Financial  Overview
9.8.4  Recent  Developments

SDMR employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach


toc

Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.

Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis

Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price

Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT